Cytochrome P-450 (CYP) enzymes are heme-containing proteins that carry out oxidative metabolism of a wide range of structurally diverse exogenous chemicals and therapeutic agents as well as endogenous compounds. For some of these xenobiotics, oxidative metabolism results in the formation of toxic, mutagenic, or carcinogenic metabolites. In the past, the role of CYP enzymes in metabolism and chemical-induced toxicity was studied indirectly through use of specific antibodies or inducers and inhibitors of these enzymes. Progress in molecular biology and the ability to bioengineer animal models that do not express CYP1A2, CYP1A1, CYP1B1, CYP2E1, or both CYP1A2 and CYP2E1 isozymes has allowed for direct investigations of the in vivo role of these enzymes in the metabolism, toxicity, and carcinogenicity of xenobiotics. This article reviews research conducted to date that utilizes these genetically bioengineered mice in metabolism, toxicity, or carcinogenicity studies of chemicals. Some studies showed a positive correlation between in vivo results and in vitro predictions for the role of a specific CYP in chemical-induced effects, whereas other studies did not support in vitro predictions. Work reviewed herein demonstrates the importance of using animal models for investigating the role of specific CYP enzymes in metabolism and chemical-induced toxicity or carcinogenicity rather than relying solely on in vitro techniques. Eventually, studies of this nature will facilitate a more accurate assessment of human risks with regard to chemicals by helping us to understand the relationships between chemical metabolism, carcinogenicity, and polymorphisms in CYP enzymes.
INTRODUCTION
Collectively, cytochrome P-450 (CYP) enzymes refer to a superfamily of heme-containing proteins that carry out phase-I oxidative metabolism of a wide array of structurally diverse endogenous and foreign compounds. Many of these chemicals are activated via the CYP enzymes to produce highly toxic, mutagenic, and/or carcinogenic metabolic intermediates. Marked species-dependent quantitative and qualitative differences in the activation of many of these procarcinogens are well known between animals and humans. Additionally, human polymorphisms in CYP enzymes may increase or CYP2E1 KrrocK-OuT (CYP2E1-l-) MICE CYP2E is a well-conserved xenobiotic-metabolizing CYP enzyme. CYP2E1 is expressed in liver, kidney, na-sal mucosa, brain, lung, and other tissues (13, 32, 65, 71) . CYP2E is inducible by ethanol, acetone, and other low-molecular weight substrates. This enzyme is also strongly influenced by nutritional and physiological conditions. It is inducible by high-fat diet, starvation, and diabetes.
To date at least 50 different chemicals are thought to be metabolized by this isozyme (39) . CYP2E1 catalyzes the metabolism of compounds with widely diverse structures, most of which are small lipid-soluble molecules (27) . Evidence CYP2E1-l-mice were first used to assess the hepatotoxicity of acetaminophen, a widely used analgesic that causes liver and renal injury at high doses. CYP-mediated activation of acetaminophen to N-acetyl-p-benzoquinone imine is thought to be a prerequisite for toxicity by this drug (Figure 1 ). CYP2E1-l-mice were found to be less sensitive to acetaminophen-induced liver and renal toxicity when compared to wild-type animals, which indicated that this CYP enzyme plays an important role in the bioactivation of acetaminophen (42) . However, at high doses (above 600 mg/kg), acetaminophen exhibited some signs of toxicity in CYP2E null mice. It was concluded that other enzymes may contribute to acetaminophen metabolism to the toxic metabolite. Subsequent FIGURE 1.-A proposed summary scheme of acetaminophen metabolism. ' studies therefore investigated the toxicity of acetaminophen in CYP1A2 and CYP2E1 double-null mice (79 (78) . AN has been shown to be metabolized to 2-cyanoethylene oxide (CEO) (Figure 2) , and in vitro studies have implicated CYP2E1 as the major isozyme (26, 27, 34) . Oxidative metabolism is believed to play a significant role in the toxicity and carcinogenicity of this chemical (34) . In wild-type mice, AN is metabolized to CEO, and both AN and CEO conjugate with glutathione, resulting in the excretion of a number of mercapturic acids ( Figure 2 (72) . These findings are consistent with earlier in vitro studies with human and rat hepatic microsomes, which indicated that CYP2E1 is the major catalyst of AN epoxidation (27, 34) . In contrast to the earlier in vitro studies (34) (23) . Assessment of 
Acrylamide
Acrylamide (AM) is a neurotoxicant in rodents and humans and a known animal carcinogen. AM is commonly used in the synthesis of plastics and polymers, and it is also used as a grouting agent and flocculent. In rodents, AM is metabolized to glycidamide (GA), and both AM and GA undergo conjugation with glutathione ( Figure 4) . To determine the role of CYP2E in the metabolism of AM in vivo, wild-type and CYP2E1-l-mice were administered 50 mg/kg [13C]AM by gavage. Urine was collected for 24 hours, and urinary metabolites were characterized using '3C nuclear magnetic resonance spectroscopy (72) . Wild-type mice excreted metabolites derived from GA and from direct AM conjugation with GSH ( Figure 4 ). Only metabolites derived from direct GSH conjugation with AM were detected in the urine of CYP2E1 /-mice (72 (3, 40, 63 (77) . Carbon tetrachloride has been shown to undergo a CYP-mediated 1-electron reduction to formFIGURE 5.-A proposed summary scheme of benzene metabolism. CYP2E 1 plays an important role in carbon tetrachlorideinduced liver injury.
Chloroform
Studies of chloroform toxicity were recently reported in CYP2El-j-and wild-type animals (9) . Chloroform induced liver, kidney, and nasal cavity tumors in mice (48) . It (30) .
Ethanol
Ethanol is a known inducer of CYP2E (60) , and formation of reactive free oxygen radicals in vivo is thought to be responsible for ethanol-induced liver injury (37) . In vivo induction of CYP2E by ethanol was suspected as a contributing factor in the generation of oxygen species and subsequent liver injury (219). Recent studies examined these relationships by investigating the effect of ethanol in CYP2El-/-mice following long term (4-week) intragastric administration of ethanol to CYP2E1-l-and wild-type mice (38) . In general, there were no significant differences in ethanol elimination rates, liver histology, and free radical formation between CYP2El -/ -and wild-type mice exposed to ethanol for 4 weeks (38) . It was concluded from this work that CYP2E 1 plays a minimal role (if any) in ethanol-induced liver injury.
The CYP1A subfamily consists of 2 members (CYP1A1 and CYP 1 A2), which are believed to be located on the same chromosome in mammals (29, 75) . CYP1A is implicated in the oxidation of a number of environmental chemicals, including polycyclic hydrocarbons, heterocyclic amines, and aromatic amines (33) . CYP1A1 1 and CYP 1 A2 are structurally similar, share most physicochemical properties, and are induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and 3-methylcholanthrene (1, 33) . Despite the structural similarity between CYP1A1 and CYP 1 A2, substrate specificity has been observed. Benzo(a)pyrene (BaP) is specifically metabolized by CYP1A1, whereas acetanilide is metabolized by CYP1A2 (6, 33 ). An aryl hydrocarbon receptor (AhR)-null mouse was produced and completely lacks the expression of CYP1A1 and exhibits low expression of CYP 1 A2 and uridine diphosphate-glucuronosyltranferase (17) . CYP1A2 does not seem to be under regulatory control of AhR as it was induced in piperonyl butoxide and acenaphthylene-treated null mice (62) .
TCDD
Using this null mice model, the environmental hazard TCDD has been studied (16, 24 (35) . Although the 2 isozymes overlap in their substrate specificities, CYP1A2 is primarily involved in the metabolism of toxicologically significant compounds, including aflatoxin B 1, a series of aromatic amines, including 2-acetylaminofluorene, 2-aminoanthracene, 2-aminofluorene, and acetaminophen, and the food-derived heterocyclic amines (2, 44) . Two different laboratories generated mouse lines lacking a functional CYP1A2 gene using the same genomic clone derived from an 129/Sv library (43, 55 (46) suggested that hepatic CYP1A2 protects against hyperoxic lung injury and is supported by studies using a CYP inhibitor in oxygen-induced lung injury in rats (47) . To test this hypothesis, wild-type and CYP1A2 -l-mice were exposed to hyperoxia or room air. Mortality in null mice was greater than that observed for wild-type mice, and lungs of surviving null mice exhibited greater damage than did similarly exposed wildtype animals (46 
Acetaminophen
Acetaminophen is a classic example of a chemical that undergoes CYP-mediated metabolism and liver toxicity. Experimental evidence indicated that both CYP2E and CYP 1 A2 were involved in acetaminophen-mediated toxicity (52, 74) . Acetaminophen-induced liver and kidney damage was less extensive in CYP1A2-/-mice compared with wild-type animals; however, there was no difference between CYPIA2 -l-and CYPIA2 +/+ mice in terms of the olfactory mucosal damage caused by this chemical (20) . This observation indicated that CYP1A2 is a minor contributor to the bioactivation of acetaminophen in the olfactory mucosa and that the toxicity observed in olfactory mucosa of CYPIA2 -/-mice is a result of metabolism by other enzymes (20) .
Phenacetin
Phenacetin is known to be metabolized by CYPlA2 in vitro. To determine if CYP1A2 contributes to phenacetininduced toxicity, wild-type mice or CYPlA2 -/-mice were fed 1.25% phenacetin in their diet for up to 67 weeks, and histopathological responses were compared (53) . CYP1A2 -l-mice had lower plasma levels of the metabolite acetaminophen and higher levels of the parent, compared with the wild-type mice. Compared with wildtype mice, mortality was more severe in the null mice, and analysis of the liver, kidney, spleen, and urogenital tract revealed different responses between the wild-type and null mice. Hepatomegaly and splenomegaly were present for both genotypes but were more severe in the null mouse. These data indicate that although CYP 1 A2 is involved in the toxicity of phenacetin, other pathways contribute to phenacetin-induced toxicity. 4-Aminobiphenyl (4-ABP) is a carcinogen in rodents and humans. Based on in vitro studies, metabolism of 4-ABP (N-hydroxylation) has been shown to be catalyzed by CYP1A2. CYP1A2-/-and wild-type mice were exposed to 4-ABP and analyzed at 16 months of age (36) . Significant differences were not noted between genotypes for hepatocellular adenoma, carcinoma, or preneoplastic foci, whereas small differences were found for specific types of foci. This study indicates that CYP1A2 may not be the only enzyme involved in the activation of 4-ABP and the production of liver tumors (36) . However, a significantly greater incidence of eosinophilic and clear foci and lesser incidence of basophilic foci were observed in CYP1A2-/-mice compared to wild-type mice (36 (12) investigated the influence of CYP1A2 on the hepatic sequestration and distribution of TCDD and a variety of related compounds using agematched CYP lA2 -j-, C57BL/6N, and 129/Sv mice.
4-Aminobiphenyl
From liver:adipose tissue concentration ratios, no hepatic sequestering of TCDD and 2,3,4,7,8-pentachlorodibenzofuran was found in CYPIA2-1-mice (12) .
As a new member of the CYP family, CYP1Bl was first found and purified from mouse embryonic fibroblasts in the early 1990s (51, 58 (42) . However, at doses higher than 600 mg/kg, significant toxicity developed in the CYP2E] -/-mice (400 mg/kg acetaminophen produced lethality in wild-type mice). By contrast, large doses of acetaminophen (1, 200 mg/kg) resulted in a very low incidence of morbidity and mortality in the double-null animals (79) . These data were supported by an early study with chemical inhibitors of CYP1A2 and CYP2E1; this study demonstrated that whereas CYP2E mainly contributes to the bioactivation of acetaminophen at lower doses, CYP1A2 is more important in the metabolism and toxicity of acetaminophen at higher doses (70) . Snawder et al suggested that in addition to CYP2E1, CYP1A2 is also important in mediating the toxicity of acetaminophen (70 (25, 50) . This approach may prove useful for researchers seeking to study the role of CYP in tissue-specific metabolism, toxicity, and carcinogenicity.
Another area that may potentially evolve from CYP gene targeting is the bioengineering of a mouse that expresses human CYPs; such efforts would make it possible to produce &dquo;humanized transgenic mouse lines.&dquo; This animal model will provide an in vivo system for the expression of human CYPs and will be beneficial in the assessment of the role of specific human CYPs in chemical metabolism, toxicity, mutagenicity, and carcinogenicity of chemicals.
